According to the Zhitong Finance App, Qiming Medical-B (02500.HK) announced interim results for the six months ended June 30, 2026. The group obtained revenue of RMB 135 million (same unit), a year-on-year decrease of 27.6%; the owner of the parent company should have accounted for a loss of 191 million yuan, an increase of 41.9% over the previous year; and a loss of 0.44 yuan per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.